Apr 29, 2025 / 01:30PM GMT
Guido Oelkers - Swedish Orphan Biovitrum AB(publ)-President - Chief Executive Officer
Hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to the first quarter video conference of 2025 call for investors and analysts. We posted this presentation to sobi.com earlier today.
And straight to the forward-looking statement, we would like to remind you of the usual provisions on the statement about expectations, projections, or future events. Unlike stated otherwise, we will be making comments that mostly relate to the first quarter at constant exchange rate in million Swedish krona.
Let's move to the agenda. And today, we plan to cover the following key aspects of the Q1 report. I'm joined by Henrik Stenqvist, our CFO; and Lydia Abad-Franch, Head of R&D and Chief Medical Officer. We plan to review the presentation first and then have Q&A until around 4:30 Swedish time. (Event Instructions)
Let's go to slide number 4. I mean we -- as you have seen, this has been a pretty strong quarter with solid
Q1 2025 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Apr 29, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers